世界の非ステロイド系抗炎症薬(NSAID)市場:販売動向2019

QYResearchが発行した調査報告書(DATA907A5816)
◆英語タイトル:Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Report 2019
◆商品コード:DATA907A5816
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年7月(※2024年版があります。お問い合わせください。)
◆ページ数:117
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、非ステロイド系抗炎症薬(NSAID)の世界市場について調査・分析し、非ステロイド系抗炎症薬(NSAID)のメーカー別販売量、市場シェア分析、種類別販売分析(アスピリン、イブプロフェン、ナプロキセン、ナブメトン、その他)、用途別販売分析(Back Pain Treatment、Osteoarthritis Treatment、Other)、地域別販売分析(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・非ステロイド系抗炎症薬(NSAID)市場概要
・非ステロイド系抗炎症薬(NSAID)のメーカー別販売量・メーカー別シェア
・非ステロイド系抗炎症薬(NSAID)の種類別販売量(アスピリン、イブプロフェン、ナプロキセン、ナブメトン、その他)
・非ステロイド系抗炎症薬(NSAID)の用途別販売量(Back Pain Treatment、Osteoarthritis Treatment、Other)
・非ステロイド系抗炎症薬(NSAID)の地域別販売量・市場シェア
・非ステロイド系抗炎症薬(NSAID)のアメリカ市場規模(2014年-2019年)
・非ステロイド系抗炎症薬(NSAID)のヨーロッパ市場規模(2014年-2019年)
・非ステロイド系抗炎症薬(NSAID)の中国市場規模(2014年-2019年)
・非ステロイド系抗炎症薬(NSAID)の日本市場規模(2014年-2019年)
・非ステロイド系抗炎症薬(NSAID)の東南アジア市場規模(2014年-2019年)
・非ステロイド系抗炎症薬(NSAID)のインド市場規模(2014年-2019年)
・非ステロイド系抗炎症薬(NSAID)メーカー分析(企業概要、製品概要、販売量、売上、価格等)
・非ステロイド系抗炎症薬(NSAID)のコスト分析
・非ステロイド系抗炎症薬(NSAID)販売チャネル、流通業者、顧客
・非ステロイド系抗炎症薬(NSAID)の世界市場動向・機会・成長要因・課題
・非ステロイド系抗炎症薬(NSAID)の種類別世界市場予測(アスピリン、イブプロフェン、ナプロキセン、ナブメトン、その他)
・非ステロイド系抗炎症薬(NSAID)の用途別世界市場予測(Back Pain Treatment、Osteoarthritis Treatment、Other)
・非ステロイド系抗炎症薬(NSAID)のアメリカ市場予測(2019年-2025年)
・非ステロイド系抗炎症薬(NSAID)のヨーロッパ市場予測(2019年-2025年)
・非ステロイド系抗炎症薬(NSAID)の中国市場予測(2019年-2025年)
・非ステロイド系抗炎症薬(NSAID)の日本市場予測(2019年-2025年)
・非ステロイド系抗炎症薬(NSAID)の東南アジア市場予測(2019年-2025年)
・非ステロイド系抗炎症薬(NSAID)のインド市場予測(2019年-2025年)
...
【レポートの概要】

The global Non-steroidal Anti-inflammatory Drugs(NSAID) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Non-steroidal Anti-inflammatory Drugs(NSAID) market status and forecast, categorizes the global Non-steroidal Anti-inflammatory Drugs(NSAID) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Bayer
Novacap
Abbott
Pfizer
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
Glaxo Smith Kline
Reddy Pharmaceuticals
Johnson & Johnson

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others

Segment by Application
Back Pain Treatment
Osteoarthritis Treatment
Other

【レポートの目次】

Table of Contents

Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Report 2019
1 Non-steroidal Anti-inflammatory Drugs(NSAID) Market Overview
1.1 Non-steroidal Anti-inflammatory Drugs(NSAID)Product Overview
1.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Segment by Type
1.2.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Comparison by Types (2014-2025)
1.2.2 Aspirin
1.2.3 Ibuprofen
1.2.4 Naproxen
1.2.5 Nabumetone
1.2.6 Others
1.3 Non-steroidal Anti-inflammatory Drugs(NSAID) Segment by Application
1.3.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Comparison by Application (2014-2025)
1.3.1 Back Pain Treatment
1.3.2 Osteoarthritis Treatment
1.3.3 Other
1.4 Non-steroidal Anti-inflammatory Drugs(NSAID) Market by Region
1.4.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Comparison by Region (2014-2025)
1.4.2 United States Non-steroidal Anti-inflammatory Drugs(NSAID) Status and Prospect (2014-2025)
1.4.3 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Status and Prospect (2014-2025)
1.4.4 China Non-steroidal Anti-inflammatory Drugs(NSAID) Status and Prospect (2014-2025)
1.4.5 Japan Non-steroidal Anti-inflammatory Drugs(NSAID) Status and Prospect (2014-2025)
1.4.6 Southeast Asia Non-steroidal Anti-inflammatory Drugs(NSAID) Status and Prospect (2014-2025)
1.4.7 India Non-steroidal Anti-inflammatory Drugs(NSAID) Status and Prospect (2014-2025)
1.5 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Revenue (2014-2025)
1.5.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2014-2025)
1.5.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue and Growth Rate (2014-2025)

2 Non-steroidal Anti-inflammatory Drugs(NSAID) by Company, Region, Type and Application
2.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Competition by Companies
2.1.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Company (2014-2019)
2.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Revenue by Region
2.2.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Region (2014-2019)
2.2.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Region (2014-2019)
2.3 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Revenue by Type
2.3.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type (2014-2019)
2.3.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Type (2014-2019)
2.4 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Application

3 United States Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Price
3.1 United States Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Revenue (2014-2019)
3.1.1 United States Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Growth Rate (2014-2019)
3.1.2 United States Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Growth Rate (2014-2019)
3.1.3 United States Non-steroidal Anti-inflammatory Drugs(NSAID) Price Trend (2014-2019)
3.2 United States Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Company
3.3 United States Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type
3.4 United States Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application

4 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Price
4.1 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Value (2014-2019)
4.1.1 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Growth Rate (2014-2019)
4.1.2 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Growth Rate (2014-2019)
4.1.3 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Price Trend (2014-2019)
4.2 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Company
4.3 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type
4.4 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application

5 China Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Price
5.1 China Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Revenue (2014-2019)
5.1.1 China Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Growth Rate (2014-2019)
5.1.2 China Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Growth Rate (2014-2019)
5.1.3 China Non-steroidal Anti-inflammatory Drugs(NSAID) Price Trend (2014-2019)
5.2 China Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Company
5.3 China Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type
5.4 China Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application

6 Japan Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Price
6.1 Japan Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Value (2014-2019)
6.1.1 Japan Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Growth Rate (2014-2019)
6.1.2 Japan Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Growth Rate (2014-2019)
6.1.3 Japan Non-steroidal Anti-inflammatory Drugs(NSAID) Price Trend (2014-2019)
6.2 Japan Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Company
6.3 Japan Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type
6.4 Japan Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application

7 Southeast Asia Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Price
7.1 Southeast Asia Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Value (2014-2019)
7.1.1 Southeast Asia Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Non-steroidal Anti-inflammatory Drugs(NSAID) Price Trend (2014-2019)
7.2 Southeast Asia Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Company
7.3 Southeast Asia Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type
7.4 Southeast Asia Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application

8 India Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Price
8.1 India Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Value (2014-2019)
8.1.1 India Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Growth Rate (2014-2019)
8.1.2 India Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Growth Rate (2014-2019)
8.1.3 India Non-steroidal Anti-inflammatory Drugs(NSAID) Price Trend (2014-2019)
8.2 India Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Company
8.3 India Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type
8.4 India Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application

9 Company Profiles and Key Figures in Non-steroidal Anti-inflammatory Drugs(NSAID) Business
9.1 Bayer
9.1.1 Bayer Non-steroidal Anti-inflammatory Drugs(NSAID) Production Sites and Area Served
9.1.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Specification and Application
9.1.3 Bayer Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Novacap
9.2.1 Novacap Non-steroidal Anti-inflammatory Drugs(NSAID) Production Sites and Area Served
9.2.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Specification and Application
9.2.3 Novacap Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Abbott
9.3.1 Abbott Non-steroidal Anti-inflammatory Drugs(NSAID) Production Sites and Area Served
9.3.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Specification and Application
9.3.3 Abbott Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Pfizer
9.4.1 Pfizer Non-steroidal Anti-inflammatory Drugs(NSAID) Production Sites and Area Served
9.4.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Specification and Application
9.4.3 Pfizer Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Geri-Care Pharmaceuticals
9.5.1 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs(NSAID) Production Sites and Area Served
9.5.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Specification and Application
9.5.3 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Perrigo Company
9.6.1 Perrigo Company Non-steroidal Anti-inflammatory Drugs(NSAID) Production Sites and Area Served
9.6.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Specification and Application
9.6.3 Perrigo Company Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 Kopran
9.7.1 Kopran Production Sites and Area Served
9.7.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Specification and Application
9.7.3 Kopran Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
9.8 Merck Sharp & Dohme
9.8.1 Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs(NSAID) Production Sites and Area Served
9.8.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Specification and Application
9.8.3 Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business and Markets Served
9.9 Sun Pharmaceutical Industries
9.9.1 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs(NSAID) Production Sites and Area Served
9.9.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Specification and Application
9.9.3 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business and Markets Served
9.10 Glaxo Smith Kline
9.10.1 Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs(NSAID) Production Sites and Area Served
9.10.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Specification and Application
9.10.3 Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2014-2019)
9.10.4 Main Business and Markets Served
9.11 Reddy Pharmaceuticals
9.12 Johnson & Johnson

10 Non-steroidal Anti-inflammatory Drugs(NSAID) Maufacturing Cost Analysis
10.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs(NSAID)
10.4 Non-steroidal Anti-inflammatory Drugs(NSAID) Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Distributors List
11.3 Non-steroidal Anti-inflammatory Drugs(NSAID) Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Non-steroidal Anti-inflammatory Drugs(NSAID) Market Forecast
13.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Price Forecast
13.1.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Growth Forecast (2019-2025)
13.1.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Growth Forecast (2019-2025)
13.1.3 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Price Trend Forecast (2019-2025)
13.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Forecast by Region
13.2.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Forecast by Type
13.3.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Type (2019-2025)
13.3.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast by Type (2019-2025)
13.3.3 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Price Forecast by Type (2019-2025)
13.4 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の非ステロイド系抗炎症薬(NSAID)市場:販売動向2019(Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Report 2019)]についてメールでお問い合わせはこちらでお願いします。